Get all your news in one place.
100's of premium titles.
One app.
Start reading
Fortune
Fortune
Sasha Rogelberg

Mark Cuban says Trump’s new drug platform could succeed if it forces pharma managers to change: ‘If that happens, Trump gets all the credit’

Mark Cuban sits on a white chair in front of a purple background, speaking into a microphone. (Credit: Jeff Schear—Getty Images for Global Citizen)

Billionaire venture capitalist Mark Cuban has not shied away from blasting President Donald Trump’s policy decisions, but he said Trump’s latest move just might work.

The president announced on Tuesday plans to launch TrumpRx.gov, a federal-government-operated website to sell prescription drugs directly to consumers at discounted rates. Cuban founded Cost Plus Drugs, a similar direct-to-consumer (DTC) platform, in 2022 with the goal of disrupting the health care industry. The online marketplace sells hundreds of discounted generic drugs by circumventing third-party pharmacy benefit managers (PBMs), which manage prescription-drug benefits on behalf of employers and insurance companies. These PBMs then negotiate rebates with drug manufacturers, but often keep the cash generated from those rebates.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.